{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:46:13Z","timestamp":1792107973834,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41390-026-04794-y","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:27:03Z","timestamp":1769419623000},"page":"1028-1033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in treatment and prevention of pulmonary thromboembolism associated with Mycoplasma pneumoniae pneumonia in children"],"prefix":"10.1038","volume":"100","author":[{"given":"Yang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzheng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"4794_CR1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg. Microbes Infect. 11, 1508\u20131517 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"4794_CR2","volume":"14","author":"Y Sun","year":"2025","unstructured":"Sun,\u2009Y.\u2009et al. Characterizing the epidemiology of Mycoplasma pneumoniae infections in China in 2022-2024: a nationwide cross-sectional study of over 1.6 million cases. Emerg. Microbes Infect. 14, 2482703 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"4794_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/crj.13584","volume":"17","author":"L Chen","year":"2023","unstructured":"Chen,\u2009L.\u2009et al. Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children. Clin. Respir. J. 17, 187\u2013196 (2023).","journal-title":"Clin. Respir. J."},{"key":"4794_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4774-9","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children\u2019s hospital. BMC Infect. Dis. 20, 51 (2020).","journal-title":"BMC Infect. Dis."},{"key":"4794_CR5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100895","volume":"3","author":"R Rastogi","year":"2024","unstructured":"Rastogi, R. et al. Incidence, management, and outcomes of pulmonary embolism at tertiary pediatric hospitals in the United States. JACC Adv. 3, 100895 (2024).","journal-title":"JACC Adv."},{"key":"4794_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13052-024-01690-1","volume":"50","author":"P Jin","year":"2024","unstructured":"Jin, P., Han, C., Guo, W. & Xu, Y. Mycoplasma pneumoniae pneumonia-associated thromboembolism with plastic bronchitis: a series of five case reports and literature review. Ital. J. Pediatr. 50, 117 (2024).","journal-title":"Ital. J. Pediatr."},{"key":"4794_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.chest.2021.09.019","volume":"161","author":"C Ross","year":"2022","unstructured":"Ross,\u2009C.\u2009et al. Acute management of high-risk and intermediate-risk pulmonary embolism in children: a review. Chest 161, 791\u2013802 (2022).","journal-title":"Chest"},{"key":"4794_CR8","first-page":"1137","volume":"62","author":"The Respiratory Group, Pediatric Branch of the Chinese Medical Association","year":"2024","unstructured":"The Respiratory Group, Pediatric Branch of the Chinese Medical Association et al. Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. Chin. J. Pediatr. 62, 1137\u20131144 (2024).","journal-title":"Chin. J. Pediatr."},{"key":"4794_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06508-7","volume":"21","author":"JG Ahn","year":"2021","unstructured":"Ahn, J. G. et al. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect. Dis. 21, 1003 (2021).","journal-title":"BMC Infect. Dis."},{"key":"4794_CR10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","volume":"54","author":"TA Tsai","year":"2021","unstructured":"Tsai, T. A., Tsai, C. K., Kuo, K. C. & Yu, H. R. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J. Microbiol. Immunol. Infect. 54, 557\u2013565 (2021).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"4794_CR11","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel, T.\u2009L.\u2009et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 4, 4693\u20134738 (2020).","journal-title":"Blood Adv."},{"key":"4794_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.blre.2018.06.003","volume":"33","author":"ILM Klaassen","year":"2019","unstructured":"Klaassen, I. L.\u2009M.\u2009et al. Are low-molecular-weight heparins safe and effective in children? A systematic review. Blood Rev. 33, 33\u201342 (2019).","journal-title":"Blood Rev."},{"key":"4794_CR13","first-page":"81","volume":"40","author":"The Pediatric Professional Committee of the Chinese Medical Education Association","year":"2025","unstructured":"The Pediatric Professional Committee of the Chinese Medical Education Association et al. Expert consensus on the diagnosis and treatment of pulmonary thromboembolism in children. Chin. J. Appl. Clin. Pediatr. 40, 81\u201391 (2025).","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"key":"4794_CR14","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","volume":"141","author":"P Monagle","year":"2012","unstructured":"Monagle,\u2009P.\u2009et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141, e737S\u2013e801S (2012).","journal-title":"Chest"},{"key":"4794_CR15","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","volume":"7","author":"C Male","year":"2020","unstructured":"Male,\u2009C.\u2009et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 7, e18\u2013e27 (2020).","journal-title":"Lancet Haematol."},{"key":"4794_CR16","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","volume":"8","author":"J Halton","year":"2021","unstructured":"Halton,\u2009J.\u2009et al. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial. Lancet Haematol. 8, e22\u2013e33 (2021).","journal-title":"Lancet Haematol."},{"key":"4794_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.thromres.2022.11.027","volume":"221","author":"E Hassan","year":"2023","unstructured":"Hassan, E. & Motwani, J. Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism. Thromb. Res. 221, 92\u201396 (2023).","journal-title":"Thromb. Res."},{"key":"4794_CR18","unstructured":"Janssen Pharmaceuticals. Product Monograph: Xarelto\/rivaroxaban. 2021. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215859s000lbl.pdf (2025)."},{"key":"4794_CR19","unstructured":"US Food and Drug Administration. Prescribing information: ELIQUIS (apixaban) tablets. 2025. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/202155s039s040lbl.pdf (2025)."},{"key":"4794_CR20","unstructured":"US Food and Drug Administration. Prescribing information: Pradaxa (dabigatran etexilate) oral pellets. 2021. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214358s000lbl.pdf (2025)."},{"key":"4794_CR21","unstructured":"US Food and Drug Administration. Prescribing information: Pradaxa (dabigatran etexilate) capsules. 2021. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/022512s041lbl.pdf (2025)."},{"key":"4794_CR22","volume":"10","author":"T Zhang","year":"2022","unstructured":"Zhang,\u2009T.\u2009et al. Case report: cardiac multiple thrombus and pulmonary embolism associated with Mycoplasma pneumonia infection in a child. Front. Pediatr. 10, 959218 (2022).","journal-title":"Front. Pediatr."},{"key":"4794_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12887-023-04188-7","volume":"23","author":"S Song","year":"2023","unstructured":"Song, S. & Xu, Y. A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia. BMC Pediatr. 23, 370 (2023).","journal-title":"BMC Pediatr."},{"key":"4794_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1186\/s12887-024-05283-z","volume":"24","author":"R Cheng","year":"2024","unstructured":"Cheng, R., Wang, Q., Jiang, L. & Liu, L. M. Pulmonary thromboembolism due to Mycoplasma pneumoniae in children: a case report and literature review. BMC Pediatr. 24, 816 (2024).","journal-title":"BMC Pediatr."},{"key":"4794_CR25","doi-asserted-by":"crossref","first-page":"1449493","DOI":"10.3389\/fped.2025.1449493","volume":"13","author":"F Xiaoqian","year":"2025","unstructured":"Xiaoqian, F. & Hemin, L. Successful rivaroxaban and doxycycline therapy for Mycoplasma pneumonia with pulmonary embolism in children: a case report. Front. Pediatr. 13, 1449493 (2025).","journal-title":"Front. Pediatr."},{"key":"4794_CR26","first-page":"373","volume":"63","author":"J Zhang","year":"2025","unstructured":"Zhang,\u2009J.\u2009et al. Clinical characteristics and therapeutic experience with rivaroxaban in children with Mycoplasma pneumoniae pneumonia associated with pulmonary thromboembolism. Chin. J. Pediatr. 63, 373\u2013378 (2025).","journal-title":"Chin. J. Pediatr."},{"key":"4794_CR27","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","volume":"2","author":"P Monagle","year":"2018","unstructured":"Monagle,\u2009P.\u2009et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2, 3292\u20133316 (2018).","journal-title":"Blood Adv."},{"key":"4794_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2021.23182","volume":"327","author":"NA Goldenberg","year":"2022","unstructured":"Goldenberg, N. A. et al. Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial. JAMA 327, 129\u2013137 (2022).","journal-title":"JAMA"},{"key":"4794_CR29","doi-asserted-by":"crossref","first-page":"8708417","DOI":"10.1155\/2020\/8708417","volume":"2020","author":"S Saleem","year":"2020","unstructured":"Saleem, S. & Berman, B. Deep vein thrombosis and pulmonary embolism in the setting of Mycoplasma infection. Case Rep. Med. 2020, 8708417 (2020).","journal-title":"Case Rep. Med."},{"key":"4794_CR30","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1002\/ppul.26691","volume":"58","author":"S Chen","year":"2023","unstructured":"Chen, S., Ke, S., Vinturache, A., Dong, X. & Ding, G. Pulmonary embolism associated with Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 58, 3605\u20133608 (2023).","journal-title":"Pediatr Pulmonol"},{"key":"4794_CR31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcmd.2016.12.003","volume":"67","author":"G Kenet","year":"2017","unstructured":"Kenet, G., Limperger, V., Shneyder, M. & Nowak-G\u00f6ttl, U. Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents-what did we learn within the last 20 years? Blood Cell Mol. Dis. 67, 18\u201322 (2017).","journal-title":"Blood Cell Mol. Dis."},{"key":"4794_CR32","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens, S.\u2009M.\u2009et al. Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest 160, 2247\u20132259 (2021).","journal-title":"Chest"},{"key":"4794_CR33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fped.2017.00260","volume":"5","author":"C Tarango","year":"2017","unstructured":"Tarango, C. & Manco-Johnson, M. J. Pediatric thrombolysis: a practical approach. Front. Pediatr. 5, 260 (2017).","journal-title":"Front. Pediatr."},{"key":"4794_CR34","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvir.2024.100957","volume":"27","author":"E Herzog","year":"2024","unstructured":"Herzog, E. et al. Interventional treatment of pediatric venous thromboembolic disease. Tech. Vasc. Interv. Radiol. 27, 100957 (2024).","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"4794_CR35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12887-025-05472-4","volume":"25","author":"M Alsabri","year":"2025","unstructured":"Alsabri, M. et al. Epidemiology and management of massive, sub-massive, and non-massive pediatric pulmonary embolism: a systematic reviews. BMC Pediatr. 25, 330 (2025).","journal-title":"BMC Pediatr."},{"key":"4794_CR36","doi-asserted-by":"crossref","first-page":"A1047","DOI":"10.1016\/j.chest.2017.08.1080","volume":"152","author":"A Mishra","year":"2017","unstructured":"Mishra,\u2009A.\u2009et al. Comparison of catheter-directed thrombolysis vs systemic thrombolysis in pulmonary embolism: a propensity score match analysis. Chest 152, A1047 (2017).","journal-title":"Chest"},{"key":"4794_CR37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-024-00674-9","volume":"23","author":"BF Alqeeq","year":"2025","unstructured":"Alqeeq,\u2009B. F.\u2009et al. Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis. Thromb. J. 23, 4 (2025).","journal-title":"Thromb. J."},{"key":"4794_CR38","first-page":"440","volume":"28","author":"Q Zhu","year":"2021","unstructured":"Zhu, Q., Pan, T., Bai, Z. & Li, Y. Catheter directed thrombolysis in children with high-risk pulmonary embolism: a case report and literature review. Chin. Pediatr. Emerg. Med. 28, 440\u2013443 (2021).","journal-title":"Chin. Pediatr. Emerg. Med."},{"key":"4794_CR39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jacc.2020.06.065","volume":"76","author":"JB Goldberg","year":"2020","unstructured":"Goldberg,\u2009J. B.\u2009et al. Survival and right ventricular function after surgical management of acute pulmonary embolism. J. Am. Coll. Cardiol. 76, 903\u2013911 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"4794_CR40","first-page":"421","volume":"39","author":"K Huang","year":"2021","unstructured":"Huang,\u2009K.\u2009et al. Mycoplasma pneumoniae pneumonia complicated with cardiac thrombus and pulmonary embolism: a case report and literature review. J. Clin. Pediatr. 39, 421\u2013424 (2021).","journal-title":"J. Clin. Pediatr."},{"key":"4794_CR41","first-page":"535","volume":"63","author":"J Yang","year":"2025","unstructured":"Yang,\u2009J.\u2009et al. Clinical analysis of 15 cases of severe Mycoplasma pneumoniae pneumonia complicated by cardiac thrombosis in children. Chin. J. Pediatr. 63, 535\u2013540 (2025).","journal-title":"Chin. J. Pediatr."},{"key":"4794_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/etm.2021.9634","volume":"21","author":"CQ Sheng","year":"2021","unstructured":"Sheng, C. Q., Yang, C. F., Ao, Y., Zhao, Z. Y. & Li, Y. M. Mycoplasma pneumoniae pneumonia with pulmonary embolism: a study on pediatric cases in Jilin province of China. Exp. Ther. Med. 21, 201 (2021).","journal-title":"Exp. Ther. Med."},{"key":"4794_CR43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1358863X221109855","volume":"27","author":"G Chi","year":"2022","unstructured":"Chi, G., Lee, J. J., Memar Montazerin, S. & Marszalek, J. Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: a systematic review and meta-analysis. Vasc. Med. 27, 478\u2013486 (2022).","journal-title":"Vasc. Med."},{"key":"4794_CR44","volume":"11","author":"Y Zheng","year":"2021","unstructured":"Zheng, Y.\u2009et al. The level of D-dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children. Front. Cell. Infect. Microbiol. 11, 687391 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"4794_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05700-5","volume":"21","author":"X Huang","year":"2021","unstructured":"Huang, X.\u2009et al. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia. BMC Infect. Dis. 21, 14 (2021).","journal-title":"BMC Infect. Dis."},{"key":"4794_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13052-022-01344-0","volume":"48","author":"C Han","year":"2022","unstructured":"Han,\u2009C.\u2009et al. Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study. Ital. J. Pediatr. 48, 153 (2022).","journal-title":"Ital. J. Pediatr."},{"key":"4794_CR47","volume":"60","author":"Y Guan","year":"2025","unstructured":"Guan,\u2009Y.\u2009et al. Development and evaluation of a nomogram for predicting pulmonary embolism in children with severe Mycoplasma pneumoniae pneumonia. Pediatr. Pulmonol. 60, e71046 (2025).","journal-title":"Pediatr. Pulmonol."},{"key":"4794_CR48","doi-asserted-by":"crossref","first-page":"111474","DOI":"10.1016\/j.ejrad.2024.111474","volume":"176","author":"H Gu","year":"2024","unstructured":"Gu, H., Li, B., Han, Y., Yang, S. & Wang, X. Risk factors for suspected pulmonary embolism in children: complication of Mycoplasma pneumoniae pneumonia. Eur. J. Radiol. 176, 111474 (2024).","journal-title":"Eur. J. Radiol."},{"key":"4794_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10096-024-05014-3","volume":"44","author":"J Hou","year":"2025","unstructured":"Hou, J. et al. Pulmonary embolism in children with Mycoplasma pneumonia: can it be predicted? Eur. J. Clin. Microbiol. Infect. Dis. 44, 393\u2013403 (2025).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"4794_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74302-x","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang,\u2009X.\u2009et al. Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children. Sci. Rep. 14, 24043 (2024).","journal-title":"Sci. Rep."},{"key":"4794_CR51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/INF.0000000000004287","volume":"43","author":"Y Yu","year":"2024","unstructured":"Yu, Y., Jin, X., Zhang, X. & Shen, Y. Pulmonary thrombotic complication of Mycoplasma pneumoniae pneumonia in Chinese children: clinical feature and risk factor analysis. Pediatr. Infect. Dis. J. 43, 505\u2013510 (2024).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"4794_CR52","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/IDR.S459626","volume":"17","author":"C Wang","year":"2024","unstructured":"Wang,\u2009C.\u2009et al. Characteristics and outcomes of Mycoplasma pneumoniae pneumonia associated with pulmonary embolism and necrotizing pneumonia in children. Infect. Drug Resist. 17, 1961\u20131969 (2024).","journal-title":"Infect. Drug Resist."},{"key":"4794_CR53","doi-asserted-by":"crossref","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim, K.\u2009et al. Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw. Open 5, e2220949 (2022).","journal-title":"JAMA Netw. Open"},{"key":"4794_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-022-03030-9","volume":"23","author":"Y Fu","year":"2023","unstructured":"Fu,\u2009Y.\u2009et al. Clinical characteristics of 14 pediatric Mycoplasma pneumoniae pneumonia associated thrombosis: a retrospective study. BMC Cardiovasc. Disord. 23, 1 (2023).","journal-title":"BMC Cardiovasc. Disord."},{"key":"4794_CR55","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ppul.20739","volume":"43","author":"SM Brown","year":"2008","unstructured":"Brown, S. M. et al. Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors. Pediatr. Pulmonol. 43, 200\u2013202 (2008).","journal-title":"Pediatr. Pulmonol."},{"key":"4794_CR56","first-page":"956","volume":"101","author":"KD Graw-Panzer","year":"2009","unstructured":"Graw-Panzer, K. D., Verma, S., Rao, S., Miller, S. T. & Lee, H. Venous thrombosis and pulmonary embolism in a child with pneumonia due to Mycoplasma pneumoniae. J. Natl. Med. Assoc. 101, 956\u2013958 (2009).","journal-title":"J. Natl. Med. Assoc."},{"key":"4794_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12887-021-02845-3","volume":"21","author":"DW Hahn","year":"2021","unstructured":"Hahn, D. W., Atkinson, C. E. & Le, M. Multiple anatomic sites of infarction in a pediatric patient with M. pneumoniae infection, a case report. BMC Pediatr. 21, 372 (2021).","journal-title":"BMC Pediatr."},{"key":"4794_CR58","volume":"13","author":"TT Jiang","year":"2023","unstructured":"Jiang,\u2009T.\u2009T.\u2009et al. The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic. Front. Cell. Infect. Microbiol. 13, 1181402 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"4794_CR59","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3201\/eid2706.203206","volume":"27","author":"MM Lanata","year":"2021","unstructured":"Lanata, M. M. et al. Macrolide-resistant Mycoplasma pneumoniae infections in children, Ohio, USA. Emerg. Infect. Dis. 27, 1588\u20131597 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"4794_CR60","first-page":"11574","volume":"9","author":"Z Huang","year":"2016","unstructured":"Huang, Z., Zhang, B. & Cheng, B. Mycoplasma pneumoniae pneumonia complicated with pulmonary embolism: a systematic analysis of published case reports. Int. J. Clin. Exp. Med. 9, 11574\u201311581 (2016).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"4794_CR61","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-025-05084-7","volume":"19","author":"M Alsabri","year":"2025","unstructured":"Alsabri,\u2009M.\u2009et al. Systematic review of case series and case reports on pediatric pulmonary embolism. J. Med. Case Rep. 19, 76 (2025).","journal-title":"J. Med. Case Rep."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04794-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:57:24Z","timestamp":1792105044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04794-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4794"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-04794-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}